Forma Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch FMTX and buy or sell other stocks, options, and ETFs commission-free!

About FMTX

Forma Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company. engages in the research, development and commercialization of novel therapeutics for the treatment of hematologic diseases and cancers. Its product pipeline consists of FT-4202 for the treatment of sickle cell disease and other hemoglobinopathies, and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. 

CEO
Frank D. Lee, MBA
CEOFrank D. Lee, MBA
Employees
—
Employees—
Headquarters
Watertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded
2011
Founded2011
Employees
—
Employees—

FMTX Key Statistics

Market cap
957.53M
Market cap957.53M
Price-Earnings ratio
-5.00
Price-Earnings ratio-5.00
Dividend yield
—
Dividend yield—
Average volume
710.37K
Average volume710.37K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$20.68
52 Week high$20.68
52 Week low
$4.95
52 Week low$4.95
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.